Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
So what: Last November, Verigy agreed to purchase rival LTX-Credence
Now what: Today, Verigy's board announced the Advantest offer is "superior" and it will withdraw its recommendation in favor of acquiring LTX-Credence. This sets the stage for a legal battle, with a likely outcome that Verigy can get out of the agreement with LTX-Credence (though there may be a fee involved to quit the deal). This gives Verigy good odds of being acquired by Advantest for $15 per share, an 18% premium to Friday's close.
Interested in more info on Verigy? Add it to your watchlist by clicking here.
Fool contributor Cindy Johnson does not own shares of any company named above. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.